Heska Corp (HSKA) 10-K Annual Report March 2016

Heska Corporation (NASDAQ: HSKA - News; "Heska" or the "Company"), a provider of advanced veterinary diagnostic and specialty products, today reported financial results for its fourth quarter and year ended December 31, 2015.

Fourth Quarter 2015 Highlights with Prior Year Comparison:


•	Revenue up 22%.


•	Gross profit up 22%.


•	Operating income up 103%.


•	Net income attributable to Heska up 144% to 28 cents per diluted share, from 12 cents.

Full Year 2015 Highlights with Prior Year Comparison:


•	Consolidated 2015 revenue rose 16% to a record of $104.6 million, from $89.8 million in 2014.


•	Gross profit increased 24% and Gross Margin increased 2.5 percentage points.


•	Operating income increased 194%.


•	Net income attributable to Heska doubled from $2.6 million to $5.2 million.


•	Net income attributable to Heska rose to 74 cents per diluted share from 41 cents.


•	Stockholders' equity in 2015 increased $10.4 million to $63.5 million.

Kevin Wilson, Heska's Chief Executive Officer and President, commented that, “Heska delivered for customers and shareholders in a big way during the fourth quarter and for all of 2015. The hard working people of Heska have brilliantly reworked Heska's products, teams, cost structure, business model, and narratives to lead the competition and set the pace. And customers have responded by rewarding Heska with net customer gains in all key segments, including the highly competitive blood analyzer space where roughly 80% of 2015 customers for key analyzers upgraded to Heska from a competitor or were new users. Heska is executing well, our new products pipeline is rich, our prospects pipeline is at record levels, our re-investment in Heska is expanding, and our team is winning with an unwavering focus on customer needs. As we enter 2016, I'd like to congratulate the people of Heska on their most recent great results. Heska's blood diagnostics team out-executed the competition in 2015. I am excited to see it continue. Heska's single use products posted a fantastic 2015 performance and that team is preparing 2016 for quantum leaps in the near future. Heska Imaging impressed in 2015 and is readying products to again set

The following information was filed by Heska Corp (HSKA) on Thursday, March 3, 2016 as an 8K 2.02 statement, which is an earnings press release pertaining to results of operations and financial condition. It may be helpful to assess the quality of management by comparing the information in the press release to the information in the accompanying 10-K Annual Report statement of earnings and operation as management may choose to highlight particular information in the press release.

Please wait while we load the requested 10-K report or click the link below:

https://last10k.com/sec-filings/report/1038133/000103813316000212/heska-12312015x10k.htm

View differences made from one year to another to evaluate Heska Corp's financial trajectory

Compare SEC Filings Year-over-Year (YoY) and Quarter-over-Quarter (QoQ) — *Sample 10-K Year-over-Year (YoY) Comparison*

Compare this 10-K Annual Report to its predecessor by reading our highlights to see what text and tables were ~~removed~~ , added and changed by Heska Corp.

Continue

Assess how Heska Corp's management team is paid from their Annual Proxy

Heska Corp's Definitive Proxy Statement (Form DEF 14A) filed after their 2016 10-K Annual Report includes:

Voting Procedures
Board Members
Executive Team
Salaries, Bonuses, Perks
Peers / Competitors

Continue

Financial Statements, Disclosures and Schedules

Inside this 10-K Annual Report

Material Contracts, Statements, Certifications & more

Heska Corp provided additional information to their SEC Filing as exhibits

Exhibit 10.4: Material Contract

Exhibit 10.5: Material Contract

Exhibit 10.6: Material Contract

Exhibit 10.10: Material Contract

Exhibit 10.11: Material Contract

Exhibit 10.12: Material Contract

Exhibit 10.15: Material Contract

Exhibit 10.36: Material Contract

Exhibit 10.54: Material Contract

Exhibit 10.68: Material Contract

Exhibit 10.77: Material Contract

Exhibit 10.78: Material Contract

Exhibit 21.1: Subsidaries Of The Registrant

Exhibit 23.1: Consents Of Experts And Counsel

Exhibit 31.1: Rule 13A-14(A)/15D-14(A) Certification

Exhibit 31.2: Rule 13A-14(A)/15D-14(A) Certification

Exhibit 32.1: Section 1350 Certification

Ticker: HSKA
CIK: 1038133
Form Type: 10-K Annual Report
Accession Number: 0001038133-16-000212
Submitted to the SEC: Tue Mar 15 2016 5:19:23 PM EST
Accepted by the SEC: Tue Mar 15 2016
Period: Thursday, December 31, 2015
Industry: Biological Products No Disgnostic Substances